Adsilico
Adsilico has developed a method for trialling new devices before entering human clinical tests that the company claims reduces costs, accelerates R&D timelines and eliminates the need for animal testing.
Leeds, UKadsilico.uk ↗
Total raised
€4.1M
€4,091,854
Funding rounds
1
Investors
2
distinct backers
Active since
2024-02
latest 2024-02
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood24
base rate 30% for Other
- ▼ Overdue vs cohort gap
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-02-26 | Other | €4.1M | Northern Gritstone,Parkwalk Advisors | View deal → |